In the intensive care units of Dhaka's government hospitals, patients are arriving with one illness and, in many cases, acquiring another far more lethal one — bacteria that modern medicine can no longer reliably defeat. Researchers have documented a mortality rate exceeding ninety percent among those who develop confirmed drug-resistant infections, a figure that speaks not only to microbial evolution but to the fragility of healing institutions under strain. Yet the same research carries an uncommon gift: proof that disciplined infection control can reduce deaths by eighty-six percent, remind
Drug-resistant bacteria surge in Bangladesh ICUs, but prevention measures cut deaths 86%
Over 90% of ICU patients who developed confirmed drug-resistant bacterial infections died, with 105 of 198 initially uninfected patients acquiring these bacteria during hospital care.
A hospital should be a place of healing, not a place where patients acquire life-threatening infections
Mark
Why does more than half of patients who arrive uninfected leave carrying these bacteria? Is the hospital itself the source?
Mimi
Not exactly. The bacteria are already in the environment—in other patients, in healthcare workers' hands, in surfaces. What the study shows is that once you're in an ICU bed, especially in an overcrowded one, you're exposed constantly. Without rigorous infection control, you will acquire them.
Mark
And once you have them, you're essentially doomed?
Mimi
Not quite. Carrying the bacteria and having an infection are different things. But yes—if you develop a confirmed infection from these resistant strains, the mortality is over 90 percent. That's the terrifying part.
Mark
So why did the second study show such a dramatic turnaround? What changed?
Mimi
The basics. Better hand hygiene, cleaning protocols, surveillance to catch problems early, and doctors using antibiotics more carefully instead of reflexively. Nothing exotic. Just discipline and resources applied consistently.
Mark
Is this replicable in other hospitals in Bangladesh?
Mimi
That's the hope. The intervention worked in one hospital over seven months. The question is whether other hospitals have the will and resources to do the same thing. The research proves it's possible. Implementation is the harder part.
Mark
What happens if they don't?
Mimi
The bacteria keep spreading, the death rates stay catastrophic, and patients keep acquiring infections they didn't have when they arrived. The hospital becomes a vector for resistance instead of a place of healing.
Il Polso
- More than half of ICU patients who arrived infection-free acquired drug-resistant bacteria during their hospital stay — meaning the ward itself had become a vector of harm.
- Four bacterial strains, now resistant to standard antibiotics, are moving silently through overcrowded Dhaka ICUs, colonizing patients before erupting into infections that kill more than nine in ten who develop them.
- Genetic sequencing revealed that in some cases, the very strain a patient carried upon arrival was the one that ultimately killed them — a chilling portrait of vulnerability becoming fate.
- A seven-month infection prevention intervention at one hospital slashed bloodstream infections by 86% and reduced deaths from 26 to just 4 per 100 admissions, proving the crisis is not beyond reach.
- The central question now is whether Bangladesh's hospital authorities and policymakers will treat basic hygiene, surveillance, and antibiotic stewardship as urgent necessities rather than aspirational ideals.
In the intensive care units of Dhaka's government hospitals, patients are arriving with one illness and, in many cases, acquiring another far more lethal one — bacteria that modern medicine can no longer reliably defeat. Researchers have documented a mortality rate exceeding ninety percent among those who develop confirmed drug-resistant infections, a figure that speaks not only to microbial evolution but to the fragility of healing institutions under strain. Yet the same research carries an uncommon gift: proof that disciplined infection control can reduce deaths by eighty-six percent, reminding us that catastrophe is not destiny, and that the architecture of care still matters enormously.
Inside Dhaka's government hospital ICUs, a quiet crisis is compounding. Patients arrive seeking care for one condition and, far too often, leave carrying bacteria their bodies — and modern antibiotics — cannot overcome. Researchers at icddr,b have tracked what unfolds when drug-resistant microbes take hold in overcrowded, under-resourced wards: more than nine in ten patients who develop confirmed infections die there.
Two studies examined 763 patients between mid-2023 and early 2024, following four bacterial strains — E. coli, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa — as they moved through ICU populations and evolved beyond the reach of standard treatment. Nearly half of all admissions already carried these bacteria without symptoms. More troubling still, 105 of the 198 patients who tested negative on arrival acquired the bacteria during their stay. Genetic analysis confirmed that transmission was happening inside the hospital itself — and that in some cases, the strain a patient had been silently carrying became the infection that killed them.
The mortality figures are staggering, but the second study offered something rarer: evidence of what can be done. When one hospital implemented sustained infection prevention measures over seven months — improved hygiene, active surveillance, responsible antibiotic use — bloodstream infections fell by 86 percent, and deaths dropped from 26 to 4 per 100 admissions. These were not incremental gains. They were the difference between a ward where fatal infections were routine and one where patients were genuinely protected.
Dr. Fahmida Chowdhury, who leads icddr,b's Antimicrobial Resistance Research Unit, put the moral stakes directly: a hospital must be a place of healing, not a source of new harm. The research makes clear that the catastrophic outcomes now unfolding are not inevitable. Whether Bangladesh's policymakers will act on that knowledge — treating infection control not as a luxury but as the foundation of patient safety — is the question that now presses hardest.
Inside the intensive care units of Dhaka's government hospitals, something alarming is taking root. Patients arrive seeking treatment for one condition and leave—if they leave at all—carrying bacteria their bodies cannot fight. Researchers at the International Centre for Diarrhoeal Disease Research, Bangladesh, have documented what happens when drug-resistant microbes take hold in resource-constrained wards: more than nine in ten infected patients die.
Two new studies examined 763 patients at a Dhaka hospital between mid-2023 and early 2024, tracking how four common bacteria—E. coli, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa—move through ICU populations and evolve beyond the reach of standard antibiotics. The first study, published in Microbiology Spectrum and funded by the US Centers for Disease Control and Prevention, followed 373 critically ill adults using laboratory tests and genetic sequencing to map the bacteria's path from patient to patient and from harmless colonization to lethal infection.
The numbers reveal a troubling pattern. Nearly half of all ICU admissions—48.5 percent—already carried these resistant bacteria without symptoms. But the more disturbing finding emerged among the 198 patients who tested negative upon arrival: 105 of them, or 53 percent, acquired the bacteria during their hospital stay. This was not contamination from the outside world. This was transmission happening inside the walls meant to heal them. Genetic analysis showed that in some cases, the exact same bacterial strain a patient had been carrying later became the infection that killed them.
Carrying bacteria does not automatically mean infection, but it means vulnerability. Patients colonized with these microbes face elevated risk of serious illness and can spread the pathogens to others. When confirmed infections did develop, the mortality was staggering: more than 90 percent of those patients died in the ICU. Researchers attributed this catastrophic death rate to the realities of overcrowded wards with limited treatment options and inadequate infection control infrastructure.
Yet the second study offered something rare in this landscape: evidence of what works. When a hospital implemented sustained infection prevention and control measures over seven months, the results were dramatic. Bloodstream infections dropped from 28 cases per 100 admissions to just four—an 86 percent reduction. Deaths fell from 26 per 100 admissions to four. These were not marginal improvements. They were the difference between a ward where patients routinely acquired fatal infections and one where basic hygiene, surveillance, and responsible antibiotic use actually protected lives.
Dr. Fahmida Chowdhury, who leads the Antimicrobial Resistance Research Unit at icddr,b, framed the stakes plainly: a hospital should be a place of healing, not a place where patients acquire life-threatening infections while seeking treatment. The research suggests that outcome is not inevitable. Strengthening infection prevention, improving hospital hygiene, and ensuring antibiotics are used judiciously are not luxuries in resource-constrained settings—they are the foundation of patient safety. The question now is whether Bangladesh's hospital authorities and policymakers will treat them as such.
Citazioni salienti
A hospital should be a place of healing, not a place where patients acquire another potentially life-threatening infection while seeking treatment.— Dr. Fahmida Chowdhury, Antimicrobial Resistance Research Unit, icddr,b
Strengthening basic infection prevention and control measures can dramatically reduce infections and deaths even where drug-resistant bacteria are widespread.— Tahmeed Ahmed, Executive Director, icddr,b
Vuoi la storia completa?
Leggi l'originale su The Daily Star ↗
Health & Medicine